Masking Chimeric Antigen Receptor T Cells For Tumor-Specific Activation
Patent No. EP3313874 (titled "Masking Chimeric Antigen Receptor T Cells For Tumor-Specific Activation") was filed by University OF Southern California on Jun 27, 2016. The application was issued on Mar 10, 2021.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3313874
- Application Number
- EP16815514A
- Filing Date
- Jun 27, 2016
- Status
- Revoked
- Aug 19, 2022
- Publication Date
- Mar 10, 2021
- External Links
- Slate, Register , Google Patents